Erlotinib in lung cancer - Reply Journal Article
| Authors: | Pao, W.; Ladanyi, M.; Miller, V. A. |
| Article Title: | Erlotinib in lung cancer - Reply |
| Keywords: | cancer chemotherapy; cancer survival; treatment outcome; clinical trial; erlotinib; placebo; drug efficacy; letter; lung non small cell cancer; docetaxel; randomization; pemetrexed |
| Journal Title: | New England Journal of Medicine |
| Volume: | 353 |
| Issue: | 16 |
| ISSN: | 0028-4793 |
| Publisher: | Massachusetts Medical Society |
| Date Published: | 2005-10-20 |
| Start Page: | 1740 |
| Language: | English |
| DOI: | 10.1056/NEJMc052173 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 10" - "Export Date: 24 October 2012" - "CODEN: NEJMA" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
